Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The association between bone mineral density (BMD) and hepatic glycogen storage diseases (GSDs) is still unclear. To evaluate the BMD of patients with GSD I, IIIa and IXα, a cross-sectional study was performed, including 23 patients (GSD Ia = 13, Ib = 5, IIIa = 2 and IXα = 3; median age = 11.9 years; IQ = 10.9-20.1) who underwent a dual-energy X-ray absorptiometry (DXA). Osteocalcin (OC, = 18), procollagen type 1 N-terminal propeptide (P1NP, = 19), collagen type 1 C-terminal telopeptide (CTX, = 18) and 25-OH Vitamin D ( = 23) were also measured. The participants completed a 3-day food diary ( = 20). Low BMD was defined as a Z-score ≤ -2.0. All participants were receiving uncooked cornstarch (median dosage = 6.3 g/kg/day) at inclusion, and 11 (47.8%) presented good metabolic control. Three (13%) patients (GSD Ia = 1, with poor metabolic control; IIIa = 2, both with high CPK levels) had a BMD ≤ -2.0. CTX, OC and P1NP correlated negatively with body weight and age. 25-OH Vitamin D concentration was decreased in seven (30.4%) patients. Our data suggest that patients with hepatic GSDs may have low BMD, especially in the presence of muscular involvement and poor metabolic control. Systematic nutritional monitoring of these patients is essential.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469033 | PMC |
| http://dx.doi.org/10.3390/nu13092987 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring the genetic alterations of Gorham-Stout disease.
Front Endocrinol (Lausanne)
September 2025
Bone Physiopathology Research Unit, Translational Pediatric and Clinical Genetic Research Division, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
The "vanishing bone disease" or Gorham-Stout disease (GSD) is a very rare disorder characterized by massive lymphatic and angiomatous proliferation accompanied by progressive osteolysis, without the deposition of new bone matrix. Because of its rare and complex clinical features, diagnosis is challenging and its etiopathogenesis is not completely known; the genetic basis of GSD has been hypothesized and different mutations have been reported in patients. Our review aims to describe all these genetic alterations found in GSD patients and their association with clinical features.
View Article and Find Full Text PDFEstimated glomerular filtration rate in post COVID-19 patients at 3-6 months and 12-18 months after infection.
Ren Fail
December 2025
Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Background: Some degree of renal impairment is common during acute COVID-19 infection. However, it remains unclear whether this impairment is temporary or persists long term. In this study we compare kidney function ( estimated glomerular filtration rate [eGFR]) during infection, 3-6 months and 12-18 months after infection; the relationship between patient characteristics and eGFR in post COVID-19 patients; and the difference in eGFR between post COVID-19 patients and controls.
View Article and Find Full Text PDFPeriprosthetic joint infection (PJI) is a severe and challenging complication following joint replacement that significantly impacts patient outcomes and implant longevity. Various factors contribute to PJI onset, including patient-related comorbidities and surgical procedures. Preventive strategies are categorized into preoperative, perioperative, and postoperative measures.
View Article and Find Full Text PDFLiver Transplantation as a Metabolic Treatment in Glycogen Storage Disease Type Ia.
JCEM Case Rep
October 2025
Department of Endocrinology and Metabolism, Baskent University, Cankaya, Ankara 06530, Turkey.
Glycogen storage disease type Ia (GSD Ia) is a rare autosomal recessive metabolic disorder characterized by glucose-6-phosphatase deficiency, leading to severe fasting hypoglycemia, hypertriglyceridemia, hyperuricemia, hepatic adenomas, and osteoporosis. While intensive dietary and pharmacologic therapy remains the cornerstone of treatment, a subset of patients fails to achieve metabolic control and develops life-altering complications. We report the case of a 20-year-old male with genetically confirmed GSD Ia who exhibited persistent hypoglycemia, severe hyperlipidemia, hepatic adenomas, and osteoporosis despite optimal medical management.
View Article and Find Full Text PDFGlucose dynamics in glycogen storage disease type IXa with novel PHKA2 variants: insights from our experience and a comprehensive review of the disease spectrum.
Hormones (Athens)
August 2025
Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, via Massarenti 9, Bologna, Italy.
Background: Glycogen storage disease type IXa (GSD IXa), caused by phosphorylase kinase mutations, primarily PHKA2, presents variably from mild hepatomegaly to severe liver dysfunction or isolated ketotic hypoglycemia. Its phenotypic overlap with other metabolic disorders complicates diagnosis, requiring genetic confirmation.
Methods: We retrospectively analyzed clinical, biochemical, genetic, and radiological data from patients affected by GSD IXa diagnosed at our regional metabolic disease center in Bologna (Emilia-Romagna, Italy) over recent decades and we reviewed the relevant scientific literature on the pathology.